PRNewsWire - Health

RESULTS FROM AMGEN'S PHASE 2 OBESITY STUDY OF MONTHLY MARITIDE PRESENTED AT THE AMERICAN DIABETES ASSOCIATION 85TH SCIENTIFIC SESSIONS
New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
Dialysis Patient Citizens Applauds Texas Legislature for Passing Historic Bill Expanding Affordable Medigap Access for Dialysis and ALS Patients
MySmile Celebrates Independence Day with 25% Off Sitewide - Smile Brighter All Week Long!